Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6315631rdf:typepubmed:Citationlld:pubmed
pubmed-article:6315631lifeskim:mentionsumls-concept:C0008972lld:lifeskim
pubmed-article:6315631lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:6315631lifeskim:mentionsumls-concept:C0006826lld:lifeskim
pubmed-article:6315631lifeskim:mentionsumls-concept:C0205474lld:lifeskim
pubmed-article:6315631lifeskim:mentionsumls-concept:C0016762lld:lifeskim
pubmed-article:6315631lifeskim:mentionsumls-concept:C0022173lld:lifeskim
pubmed-article:6315631pubmed:dateCreated1984-1-7lld:pubmed
pubmed-article:6315631pubmed:abstractTextRadioimmunoassays specific for ALD isozymes were developed for the quantification of human ALD-A, -B, and -C. The method is a double antibody radioimmunoassay consisting of purified radioiodinated ALD-A, -B, and C as ligand, chicken antibodies to ALD-A, -B, and -C, and rabbit antibodies to chicken IgG. The Iodogen method was used for the iodination of the purified isozymes. ALD-A was present in high concentration in muscle, ALD-B in adult liver, and ALD-C in adult brain. ALD-A was elevated in hepatoma tissue and hepatoma cell lines, whereas ALD-B was distinctly low. Normal serum levels for the three isozymes were determined. The ALD-A level in the serum from 41 normal subjects was 170 +/- 39 ng/ml. Serum ALD-A level was increased in many patients with cancer and muscle diseases, but not in patients with hepatitis or other benign diseases. Serum ALD-B level in 11 normal subjects was 28.5 +/- 9.2 ng/ml. Serum ALD-C level in 12 normal subjects was 2.4 +/- 0.7 ng/ml. The determination of ALD-A, -B, and -C by radioimmunoassay may be a valuable tool in biochemical and clinical studies of these isozymes.lld:pubmed
pubmed-article:6315631pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6315631pubmed:languageenglld:pubmed
pubmed-article:6315631pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6315631pubmed:citationSubsetIMlld:pubmed
pubmed-article:6315631pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6315631pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6315631pubmed:statusMEDLINElld:pubmed
pubmed-article:6315631pubmed:issn0160-3787lld:pubmed
pubmed-article:6315631pubmed:authorpubmed-author:AlpertEElld:pubmed
pubmed-article:6315631pubmed:authorpubmed-author:NagaseKKlld:pubmed
pubmed-article:6315631pubmed:authorpubmed-author:AsakaMMlld:pubmed
pubmed-article:6315631pubmed:issnTypePrintlld:pubmed
pubmed-article:6315631pubmed:volume11lld:pubmed
pubmed-article:6315631pubmed:ownerNLMlld:pubmed
pubmed-article:6315631pubmed:authorsCompleteYlld:pubmed
pubmed-article:6315631pubmed:pagination183-95lld:pubmed
pubmed-article:6315631pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:6315631pubmed:meshHeadingpubmed-meshheading:6315631-...lld:pubmed
pubmed-article:6315631pubmed:meshHeadingpubmed-meshheading:6315631-...lld:pubmed
pubmed-article:6315631pubmed:meshHeadingpubmed-meshheading:6315631-...lld:pubmed
pubmed-article:6315631pubmed:meshHeadingpubmed-meshheading:6315631-...lld:pubmed
pubmed-article:6315631pubmed:meshHeadingpubmed-meshheading:6315631-...lld:pubmed
pubmed-article:6315631pubmed:meshHeadingpubmed-meshheading:6315631-...lld:pubmed
pubmed-article:6315631pubmed:meshHeadingpubmed-meshheading:6315631-...lld:pubmed
pubmed-article:6315631pubmed:meshHeadingpubmed-meshheading:6315631-...lld:pubmed
pubmed-article:6315631pubmed:meshHeadingpubmed-meshheading:6315631-...lld:pubmed
pubmed-article:6315631pubmed:meshHeadingpubmed-meshheading:6315631-...lld:pubmed
pubmed-article:6315631pubmed:meshHeadingpubmed-meshheading:6315631-...lld:pubmed
pubmed-article:6315631pubmed:meshHeadingpubmed-meshheading:6315631-...lld:pubmed
pubmed-article:6315631pubmed:year1983lld:pubmed
pubmed-article:6315631pubmed:articleTitleBiochemical and clinical studies of aldolase isozymes in human cancer.lld:pubmed
pubmed-article:6315631pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6315631pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed